Oppenheimer Asset Management’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-29,815
| Closed | -$209K | – | 1247 |
|
|
2021
Q3 | $209K | Buy |
29,815
+1,710
| +6% | +$12K | ﹤0.01% | 1134 |
|
|
2021
Q2 | $258K | Sell |
28,105
-10,444
| -27% | -$95.9K | ﹤0.01% | 1091 |
|
|
2021
Q1 | $375K | Buy |
38,549
+801
| +2% | +$7.79K | 0.01% | 985 |
|
|
2020
Q4 | $387K | Buy |
37,748
+897
| +2% | +$9.2K | 0.01% | 941 |
|
|
2020
Q3 | $372K | Buy |
36,851
+11,082
| +43% | +$112K | 0.01% | 878 |
|
|
2020
Q2 | $269K | Buy |
25,769
+8,754
| +51% | +$91.4K | 0.01% | 962 |
|
|
2020
Q1 | $144K | Buy |
17,015
+7,110
| +72% | +$60.2K | ﹤0.01% | 1037 |
|
|
2019
Q4 | $87K | Buy |
9,905
+384
| +4% | +$3.37K | ﹤0.01% | 1235 |
|
|
2019
Q3 | $102K | Buy |
9,521
+2,737
| +40% | +$29.3K | ﹤0.01% | 1182 |
|
|
2019
Q2 | $86K | Buy |
6,784
+307
| +5% | +$3.89K | ﹤0.01% | 1261 |
|
|
2019
Q1 | $251K | Buy |
6,477
+1,454
| +29% | +$56.3K | 0.01% | 978 |
|
|
2018
Q4 | $102K | Buy |
5,023
+367
| +8% | +$7.45K | ﹤0.01% | 1185 |
|
|
2018
Q3 | $213K | Buy |
+4,656
| New | +$213K | ﹤0.01% | 1067 |
|
|
2017
Q4 | – | Sell |
-241
| Closed | -$29K | – | 1370 |
|
|
2017
Q3 | $29K | Sell |
241
-32
| -12% | -$3.85K | ﹤0.01% | 1457 |
|
|
2017
Q2 | $24K | Sell |
273
-150
| -35% | -$13.2K | ﹤0.01% | 1459 |
|
|
2017
Q1 | $16K | Buy |
+423
| New | +$16K | ﹤0.01% | 1495 |
|